Regístrese
metricas
covid
Enfermedades Infecciosas y Microbiología Clínica
Suscribe to the journal
Buscar en
Enfermedades Infecciosas y Microbiología Clínica
Toda la web
Inicio Enfermedades Infecciosas y Microbiología Clínica The 40-kDa protein of Lumbricus rubellus eradicates methicillin-resistant Staphy...
Journal Information
Back to article

Statistics

Follow this link to access the full text of the article

Scientific letter
The 40-kDa protein of Lumbricus rubellus eradicates methicillin-resistant Staphylococcusaureus in an long-term nasal carriage model
La proteína de 40 kDa de Lumbricus rubellus erradica Staphylococcus aureus resistente a la meticilina en un modelo de portador nasal a largo plazo
Zulvikar Syambani Ulhaqa,b,
Corresponding author
zulhaq@kedokteran.uin-malang.ac.id

Corresponding author.
, Anggi Sasmita Kharisma Putrib, Wahyu Picesa Sila Atmajab, Dewi Santosaningsihb
a Department of Biochemistry, Faculty of Medicine and Health Sciences, Maulana Malik Ibrahim State Islamic University of Malang, Batu, East Java, Indonesia
b Department of Clinical Microbiology, Faculty of Medicine, Brawijaya University/Dr. Saiful Anwar Hospital, Malang, East Java, Indonesia
Read
1609
Times
was read the article
617
Total PDF
992
Total HTML
Share statistics
Article information
ISSN: 0213005X
Original language: English
DOI:10.1016/j.eimc.2020.08.019
The statistics are updated each day
Year/Month Html Pdf Total
2024 November 18 8 26
2024 October 25 3 28
2024 September 39 4 43
2024 August 38 22 60
2024 July 20 6 26
2024 June 21 9 30
2024 May 21 3 24
2024 April 25 33 58
2024 March 33 28 61
2024 February 31 20 51
2024 January 44 17 61
2023 December 47 23 70
2023 November 35 17 52
2023 October 54 52 106
2023 September 23 10 33
2023 August 16 9 25
2023 July 26 57 83
2023 June 17 17 34
2023 May 34 9 43
2023 April 28 4 32
2023 March 25 46 71
2023 February 22 2 24
2023 January 29 4 33
2022 December 28 14 42
2022 November 38 18 56
2022 October 33 17 50
2022 September 32 28 60
2022 August 23 35 58
2022 July 13 6 19
2022 June 14 8 22
2022 May 16 20 36
2022 April 32 35 67
2022 March 23 6 29
2022 February 8 3 11
2022 January 12 4 16
2021 December 10 6 16
2021 October 13 2 15
2021 September 1 0 1
2021 August 2 2 4
2021 July 2 0 2
2021 June 21 10 31
Show all

Follow this link to access the full text of the article

Subscribe to our newsletter

Publish in
Enfermedades Infecciosas y Microbiología Clínica


La Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica agradece la colaboración de:

SOCIOS PROTECTORES

    - Pfizer GEP, S.L.U.
    - Shionogi, S.L.U.
    - AbbVie Spain, S.L.U.
    - Gilead Sciences, S.L.U.
    - Vircell Spain, S.L.U.
    - Roche Diagnostics, S.L.U.
    - ASTRAZENECA FARMACÉUTICA SPAIN, S.A.
    - Qiagen Iberia S.L.
    - Laboratorios ViiV Healthcare, S.L.

SOCIOS PATROCINADORES

- Becton Dickinson S.A.U.
- Janssen-Cilag, S.A.
- Angelini Farmacéutica, S.A.
- Biomerieux España, S,A.U.
- Merck Sharp & Dohme de España, S.A.
- Hologic Iberia, S.L.U.
- Laboratorios Menarini S.A.
- Accelerate Diagnostics S.L.
- Abbott Laboratories, S.A.
- Cepheid Iberia S.L.U.
- Illumina Productos de España. S.L.U.
- DiaSorin Iberia, S.A.
- GlaxoSmithKline, S.A.
- Sysmex España S.L.

Enfermedades Infecciosas y Microbiología Clínica follows the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals

es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos